Select Committee on Science and Technology Written Evidence


APPENDIX 4

Memorandum from the British Chapter of the International Society of Magnetic Resonance in Medicine

  I am writing on behalf of the British Chapter of the International Society of Magnetic Resonance in Medicine to endorse the Joint Submission forwarded to you by Dr Stephen Keevil, on behalf of a number of Scientific and Professional bodies. This details many aspects of the development of policy regarding occupational exposure to Magnetic Resonance devices.

  I would like to note that much of the basic research and early development underlying this major medical diagnostic resource occurred in Britain. In the early stages of introducing this new instrumentation into clinical use, the NRPB developed, in close consultation with the magnetic resonance (MR) community, some very useful guidance that stood the field in good stead for many years. This particularly concerned exposure of patients and volunteers, but also helped define issues that might be of concern to staff. Quite rightly at that time it was conservative, and limits were set at precautionary levels. In that and subsequent revisions it included guidance that balanced benefit against risk, and dealt with substantial health effects that might be damaging to a patient's health, rather than with the emphasis of the current European Physical Agents Directive on effects that give rise to perceived sensations, with no evidence that these lead to health effects.

  Unfortunately, as you will see from the Joint Submission, there has been very little active consultation with the MR community in the UK in the preparation of these new occupational standards and legislation. This has resulted in a Directive with limits based on considerations of phosphene induction providing a model for adverse effects on the nervous system. Such a perceived effect does not, however, equate with any short or long term harm to the individuals. At higher exposure levels a better characterised effect, peripheral nerve stimulation (PNS), has been observed in many patients and volunteers. Even though the threshold for PNS occurs at current densities some 100 times greater than the limits in the Directive, the sensations can be acceptable to both volunteers and patients, and, again, are not known to result in any long term effects. Staff performing interventional procedures have been able to perform delicate motor tasks in the presence of the switched fields, for the benefit of patients, and prohibiting such tasks will have a range of detrimental effects for both patients and staff.

  With this Directive being enforced, interventional procedures now being employed increasingly under MRI control would need to be substituted by the older techniques using X-ray monitoring, which deliver a radiation dose to both patients and staff. For staff, who perform repeated procedures, these doses are cumulative. While in the regulations governing the use of radiation, there is an appreciation of benefit to society that can be balanced against potential harm to the worker, similar considerations do not appear to apply to non-ionising radiations, where the potential hazards are much lower, albeit less well documented. Thus in order to reduce a non-documented potential risk from non-ionising radiation, both staff and patients will suffer an increased radiation dose, contrary to the general obligation to reduce individual and population radiation doses wherever possible. It is a matter of concern that none of the bodies involved in preparing either safety recommendations or legislation appear to have any obligation to consider the balance of personal risk against benefit to society.

  The Directive will prohibit staff supporting patients (often anxious individuals or children), and anaesthetists supervising patients (often children) who need to be sedated during scanning from performing these operations close to the scanner, which could compromise the scanning procedure, or observation and monitoring of the sedated patient.

  The Directive implements a concept of health for the worker that is absolute (based on World Health Organisation definitions), and deals only with short term perceived effects without consideration of the worker's ability to balance these effects against the value of the task undertaken. It also takes no account of the social benefit of the task, and a balance of the individual's exposure and society's benefit. In health employment it is common to accept certain hazards, whilst controlling these very carefully, for the benefit of the individuals treated.

  Interventional use of MR is a growing area that has potential benefit in a range of diseases, where the detailed local anatomy, the potential to obtain information on the functional status of tissues, and the lack of ionising radiation exposure offer obvious benefits. While much emphasis is currently on vascular techniques, the rapid development of new scanner technology aiding access is likely to lead to a wider range of operative procedures, biopsies, and minimally invasive therapies, all under the interactive control of a skilled operator. It is unlikely that automated approaches to these interventions will replace direct manipulation close to the magnet for some considerable period. Prohibiting these developments will adversely affect health research and practice in the UK.

  It is important to record that the magnetic resonance community has a major commitment to the safety of all involved in the use of magnetic resonance. This is effected through scientific meetings and publications, identifying good practice, and participating in the development of guidance, standards and regulations. Based upon our experience of staff and patient exposure, we feel that the Directive will limit the benefits of this technology, with no evident staff benefit.

January 2006





 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2006
Prepared 29 June 2006